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oxide. We aim to demonstrate these mechanisms by treating
GVHD murine models with human MSCs.
Methods: Balb/c host mice were subjected to 800 cGy
dose of gamma irradiation and given donor T lymphocyte
depleted bone marrow cells and CD4+ T lymphocyte from
donor C57BL/6N mice via tail vein. Some mice were treated
with 0.8x106 human MSCs. Survival rate and symptoms of
GVHD were monitored. At day 6 post HSCT, single cell
suspensions, tissue lysates and paraffin sections were
prepared from target tissues for flow cytometry to check
for donor T lymphocyte engraftment, enzyme linked
immunosorbent  assays  to  check  for  leve ls  of
proinflammatory cytokines, chemokine and regulatory
pathway testing, western blot for inducible nitric oxide
synthase (iNOS) expression and imaging by coherent
antistokes raman spectroscopy (CARS).
Results and conclusion: The immunosuppressive
functions of MSCs were documented in our GVHD models
by:
1.Observing protection of GVHD mice from death. This
may be due to the decreased engraftment of donor T
lymphocyte with concomitant decrease in levels of TNF-
α and IFN-γ and decreased RANTES expression which
is a chemokine ligand marker in target tissues.
2.Noting an increase in levels of iNOS in MSC treated mice,
which is a known immunosuppressive soluble mediator.
3.Suppression in the phosphorylation of STAT 5A/B
proteins in MSC treated mice which indicates arrest of
the T cell cycle.
4.Finally the presence of MSCs in target tissues is
documented by recording differences in chemical bond
vibratory signals between control and MSC treated
samples using CARS.
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Mycobacterium tuberculosis is an intracellular pathogen
and the causative agent of the disease tuberculosis.
Macrophages are the major immunocytes to initiate host
immunity against mycobacteria. Among the multiple
strategies employ by macrophages to defence against
mycobacteria, phagocytosis is the first step. Through
phagocytosis, macrophages could not only clear the
pathogens from infection sites, but also present antigens
derived from the engulfed bacteria to lymphoid cells.
c-Myc is a transcription factor that regulates a variety of
target genes. It can form a complex with Max and bind to
the enhancer box sequences of the promoter to mediate the
transcription. Recently, our group revealed that c-Myc has
a potential role in regulating the antimicrobial responses in
macrophages.
Here, we further revealed that c-Myc may play a positive
role in phagocytosis and contribute to host defense to
mycobacteria. Pretreatment of c-Myc inhibitor, 10058-F4,
could significantly reduce the amount of mycobacteria
internalised by macrophages. The acidification of
phagolysosome in mycobacteria infected macrophages was
also inhibited by 10058-F4. Further investigation showed
that macrophages phagocytose mycobacteria in a PI3K/Akt
independent pathway. And the action of c-Myc inhibitor
does not affect the expression levels of Rho family GTPases.
However, we found that 10058-F4 could significantly
inhibit phorsphorylation of ERK1/2 kinase, which has been
indicated to play a role in FcR mediated phagocytosis in
macrophage. In conclusion, c-Myc may play a role in
phagocytosis of mycobacteria through regulating
phorsphorylation of ERK1/2.
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Background: Despite being the commonest congenital
gastrointestinal anomaly, Meckel's diverticulum (MD) is
notoriously difficult for diagnosis due to the diversity of
presentations. We aim to review the MD patients in our
hospitals, focusing on their various presentations.
Method: Hospital notes of patients aged ≤18 with
diagnosis of MD from 2008 to 2013 were retrieved. The
demographic data, clinical presentations, treatments and
pathological results were analysed. Adult MD patients
during the same period were also recruited for analysis.
Result: Thirty children with the diagnosis of MD had
operation done (age 1 day to 17 years). Three patients were
born with persistent omphalomesenteric duct. In 4 children,
MD was an incidental finding during operation only.
